INBS

Conviction 12HealthcareScan · Thu, Jun 25, 2026

INBS$2.08-5.45%

ResistanceSupportVol 14

Vol MA14 59.58K

Mar 26Apr 14May 1May 19Jun 8Jun 25

INTELLIGENT BIO SOLUTIONS INC.SURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.ibs.inc ↗

Price2.08

Change-5.45%

Gap-1.82%

Rel volume0.37×

Avg volume64.19K

Avg $ vol154.17K

SMA 202.38

SMA 502.64

SMA 2003.55

Price vs 50-21.26%

Price vs 200-41.40%

MA stackbearish

50/200 cross—

Supertrenddown · 2.63

RSI (14)34

MACD hist-0.01

MACD crossbear · 1d

Stoch %K / %D0 / 6

ADX (14)10

+DI / −DI20 / 25

RSI divergenceBullish

MACD divergence—

ATR %+9.62%

ADR %5.83%

52w high17.92

52w low0.5500

From 52w high-88.39%

Above 52w low+278.18%

New 52w highNo

SqueezeOn · 6d

Bollinger width19.66%

%B-0.14

Donchian pos0.00%

Donchian high2.65

Donchian low2.08

AVWAP (52w high)8.67

vs AVWAP high-76.00%

AVWAP (52w low)9.68

vs AVWAP low-78.51%

OBV trendDown

Chaikin MF (20)-0.02

Today vs 20d0.37×

Avg vol (14d)59.58K

Avg vol (20d)64.19K

Avg $ vol (20d)154.17K

Market cap4.98M

RS 3m (vs SPY)-45.39%

RS 6m (vs SPY)-71.91%

RS line new highNo

Trend template3/8

Technical rank6.8

1 week-7.56%

1 month-21.51%

3 months-37.91%

6 months-63.83%

1 year+16.85%

YTD-73.64%

P/E-0.47

P/B0.56

P/S1.63

P/FCF-0.50

EPS-2.00

Div yield—

ROE-117.93%

ROA-71.11%

Debt/Eq0.18

Current2.11

EV/EBITDA0.02

Gross margin40.85%

Net margin-346.23%

Rev growth-1.90%

EPS growth-4.06%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-237.16K

Revenue1.06M

Net income-2.86M

Gross profit535.38K

Free cash flow-9.91M

IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS

ExchangeNasdaq

Shares out2.39M

Employees55

ListedWed, Dec 23, 2020

Free float1.59M

Float %98.9%

Short interest91.17K

Days to cover0.8d

Short volume53.0%

Squeeze score24 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction12 / 100

Pattern quality—

Tech rank6.8 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.91

Support2.25

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in INBS

All disclosures →

No recent disclosed trades by Congress in INBS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in INBS

No recent insider (Form 4) filings in INBS. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in INBS · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.